Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

NHC Reports Third Quarter 2023 Earnings

NHC

National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues and grant income for the quarter ended September 30, 2023 totaled $288,485,000 compared to $270,843,000 for the quarter ended September 30, 2022, an increase of 6.5%. Excluding the seven skilled nursing facilities in Massachusetts and New Hampshire in which we ceased operations in September 2022, same-facility net operating revenues increased 11.8% during the third quarter of 2023 compared to the same period a year ago.

For the quarter ended September 30, 2023, the reported GAAP net income attributable to NHC was $10,388,000 compared to a net loss of $2,429,000 for the same period in 2022. Excluding the unrealized gains or losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the quarter ended September 30, 2023 was $13,250,000 compared to $7,783,000 for the same period in 2022 (*). The increase in non-GAAP earnings for the quarter ended September 30, 2023 compared to the third quarter of 2022 was primarily due to the continued occupancy increase in our skilled nursing and assisted living facilities, skilled nursing per diem increases from some of our government payors, and the continued reduction of nurse agency staffing expenses within our operations. The GAAP diluted earnings per share was $0.68 for the quarter ended September 30, 2023 compared to a loss per share of $(0.16) for the quarter ended September 30, 2022. Adjusted diluted earnings per share were $0.86 and $0.50 for the quarters ended September 30, 2023 and 2022, respectively (*).

(*) - See the tables below that provide a reconciliation of GAAP to non-GAAP items.

About NHC

NHC affiliates operate for themselves and third parties 68 skilled nursing facilities with 8,732 beds. NHC affiliates also operate 26 assisted living communities with 1,501 units, five independent living communities with 475 units, three behavioral health hospitals, 35 homecare agencies, and 30 hospice agencies. NHC’s other services include Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at www.nhccare.com.

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

Forward-Looking Statements

Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q, and 10-K. All forward-looking statements represent NHC’s best judgment as of the date of this release.

Consolidated Statements of Operations
(in thousands, except share and per share amounts)

Three Months Ended

Nine Months Ended

September 30

September 30

2023

2022

2023

2022

(unaudited)

(unaudited)

Revenues and grant income:
Net patient revenues

$

277,005

$

260,247

$

804,617

$

776,661

Other revenues

11,480

10,596

36,013

33,584

Government stimulus income

-

-

-

10,940

Net operating revenues and grant income

288,485

270,843

840,630

821,185

Costs and expenses:
Salaries, wages and benefits

182,664

173,198

525,782

518,828

Other operating

72,490

72,883

217,213

218,279

Facility rent

10,094

10,294

30,087

30,770

Depreciation and amortization

10,135

10,253

30,266

30,011

Interest

77

137

268

451

Total costs and expenses

275,460

266,765

803,616

798,339

Income from operations

13,025

4,078

37,014

22,846

Non-operating income

4,097

2,731

12,116

8,451

Unrealized gains/(losses) on marketable equity securities

(3,093

)

(11,056

)

2,943

(11,479

)

Income/(loss) before income taxes

14,029

(4,247

)

52,073

19,818

Income tax (provision)/benefit

(3,908

)

1,140

(14,750

)

(5,415

)

Net income/(loss)

10,121

(3,107

)

37,323

14,403

Net loss attributable to noncontrolling interest

267

678

1,069

1,689

Net income/(loss) attributable to National HealthCare Corporation

$

10,388

$

(2,429

)

$

38,392

$

16,092

Net income/(loss) per common share
Basic

$

0.68

$

(0.16

)

$

2.51

$

1.04

Diluted

$

0.68

$

(0.16

)

$

2.50

$

1.04

Weighted average common shares outstanding
Basic

15,299,913

15,445,569

15,311,453

15,438,375

Diluted

15,324,511

15,445,569

15,334,269

15,477,103

Dividends declared per common share

$

0.59

$

0.57

$

1.75

$

1.69

Balance Sheet Data

September 30

December 31

(in thousands)

2023

2022

(unaudited)

Cash, cash equivalents and marketable securities

$

210,494

$

182,589

Restricted cash, cash equivalents and marketable securities

162,492

158,067

Current assets

382,578

353,932

Property and equipment, net

498,266

506,532

Total assets

1,281,907

1,275,450

Current liabilities

204,694

197,887

Stockholders' equity

887,340

877,514

Selected Operating Statistics

Three Months Ended

Nine Months Ended

September 30

September 30

2023

2022

2023

2022

(unaudited)

(unaudited)

Skilled Nursing Per Diems:
Medicare

$

551.82

$

535.60

$

552.21

$

540.30

Managed Care

489.18

429.22

460.20

425.39

Medicaid

256.46

237.61

248.99

230.79

Private Pay and Other

283.49

265.68

279.12

268.13

Average Skilled Nursing Per Diem

$

325.34

$

302.43

(1)

$

320.09

$

301.91

(1)

Skilled Nursing Patient Days:
Medicare

75,215

81,940

239,228

258,961

Managed Care

61,979

52,956

179,992

163,823

Medicaid

290,887

302,500

852,074

919,931

Private Pay and Other

170,857

169,068

492,279

489,477

Total Skilled Nursing Patient Days

598,938

606,464

(1)

1,763,573

1,832,192

(1)

(1) For the three and nine months ended September 30, 2022, the skilled nursing per diems and patient days listed above include the seven skilled nursing facilities that were located in Massachusetts and New Hampshire through August 31, 2022. NHC exited these seven skilled nursing facilities on September 1, 2022. For the three months ended September 30, 2022, the exited Massachusetts and New Hampshire skilled nursing facilities had an average skilled nursing per diem of $295.98 and 35,619 total patient days. For the nine months ended September 30, 2022, the exited Massachusetts and New Hampshire skilled nursing facilities had an average skilled nursing per diem of $294.64 and 140,105 total patient days.
The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts):

Three Months Ended

Nine Months Ended

September 30

September 30

2023

2022

2023

2022

(unaudited)

(unaudited)

Net income/(loss) attributable to National Healthcare Corporation

$

10,388

$

(2,429

)

$

38,392

$

16,092

Non-GAAP adjustments
Unrealized (gains)/losses on marketable equity securities

3,093

11,056

(2,943

)

11,479

Operating results for newly opened operations not at full capacity (2)

66

2,105

1,616

4,033

Stock-based compensation expense

708

639

2,119

1,980

Income tax (benefit)/provision on non-GAAP adjustments

(1,005

)

(3,588

)

(206

)

(4,548

)

Non-GAAP Net income

$

13,250

$

7,783

$

38,978

$

29,036

GAAP diluted earnings/(loss) per share

$

0.68

$

(0.16

)

$

2.51

$

1.04

Non-GAAP adjustments
Unrealized (gains)/losses on marketable equity securities

0.15

0.53

(0.14

)

0.56

Operating results for newly opened operations not at full capacity (2)

-

0.10

0.07

0.19

Stock-based compensation expense

0.03

0.03

0.10

0.09

Non-GAAP diluted earnings per share

$

0.86

$

0.50

$

2.54

$

1.88

(2) The newly opened operations not at full capacity for the 2023 periods presented consisted of operations opened from 2021 through 2023. This consisted of two behavioral health hospitals, two homecare agencies, and two hospice agencies. The newly opened operations for the 2022 periods presented consisted of operations opened from 2020 through 2022. This consisted of two behavioral health hospitals, one homecare agency, and one hospice agency.

Tags: